Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London · Delayed Price · Currency is GBP · Price in USD 744.27
-2.54 (-0.34%)
At close: Jan 30, 2026
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 55.45 billion as of January 30, 2026. Its market cap has decreased by -10.34% in one year.
Market Cap
55.45B
Enterprise Value
43.67B
Revenue
10.66B
Ranking
n/a
PE Ratio
16.57
Stock Price
744.27
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 55.45B, an increase of 57,588.89%. That is a compound annual growth rate of 20.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 55.45B | -5.76% |
| Dec 31, 2025 | 58.84B | -3.88% |
| Dec 31, 2024 | 61.22B | -16.52% |
| Dec 29, 2023 | 73.33B | 14.66% |
| Dec 30, 2022 | 63.95B | 31.15% |
| Dec 31, 2021 | 48.76B | 30.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.88B |